Phase I Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 18 Years or Above

Clinical trial NCT07289503 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07289503
Sponsor: Suzhou Abogen Biosciences Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus

Start date: 2025-05-27
Primary completion: 2025-09-04
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.